Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SRx Health Solutions (SRXH) Asset Writedowns and Impairment: 2016-2023

Historic Asset Writedowns and Impairment for SRx Health Solutions (SRXH) over the last 6 years, with FY2023 value amounting to $8.5 million.

  • SRx Health Solutions' Asset Writedowns and Impairment fell 6835.44% to $2.7 million in Q2 2025 from the same period last year, while for Jun 2025 it was $2.8 million, marking a year-over-year decrease of 6672.6%. This contributed to the annual value of $8.5 million for FY2023, which is 37164.18% up from last year.
  • According to the latest figures from FY2023, SRx Health Solutions' Asset Writedowns and Impairment is $8.5 million, which was up 37164.18% from $1.8 million recorded in FY2022.
  • Over the past 5 years, SRx Health Solutions' Asset Writedowns and Impairment peaked at $8.5 million during FY2023, and registered a low of $265000.0 during FY2021.
  • Moreover, its 4-year median value for Asset Writedowns and Impairment was $1.3 million (2019), whereas its average is $2.9 million.
  • Per our database at Business Quant, SRx Health Solutions' Asset Writedowns and Impairment skyrocketed by 58264.15% in 2022 and then soared by 37164.18% in 2023.
  • SRx Health Solutions' Asset Writedowns and Impairment (Annual) stood at $889000.0 in 2019, then crashed by 70.19% to $265000.0 in 2021, then skyrocketed by 582.64% to $1.8 million in 2022, then soared by 371.64% to $8.5 million in 2023.
  • Its Asset Writedowns and Impairment was $8.5 million in FY2023, compared to $1.8 million in FY2022 and $265000.0 in FY2021.